Leads the planning, execution, and delivery of complex global clinical studies, managing timelines, budgets, and quality.
Oversees CROs and external vendors, ensuring alignment with study timelines, budgets, and contractual obligations.
Drives cross-functional collaboration and communicates study progress, risks, and decisions to stakeholders.
Deciphera, a member of Ono Pharmaceutical Co., Ltd., is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines for cancer, neurologic, and autoimmune diseases. The company cultivates an inclusive culture that values curiosity, creativity, and shared accountability, empowering individuals to challenge the unknown together.
Contribute to the technical approach for evaluating AI agents in diagnosing, treating, and researching rare and progressive diseases.
Build ground-truth benchmark datasets from studies and novel work that rigorously test agents' analytical and interpretive skills.
Collaborate with scientists, physician-scientists, engineers, and computational biologists to define strategy across multiple benchmarks.
Latch builds rigorous scientific benchmarks for AI agents across biology, measuring whether agents can handle real biological workflows. An early, tight-knit team, Latch practices radical transparency, uses AI constantly, and fosters a culture of respect, expert judgment, and community activities.
Lead the in-house Clinical Research Associate and Clinical Budget Analyst teams overseeing study start-up activities including regulatory documentation, site budgets, and vendor management.
Establish and apply start-up best practices, representing Clinical Operations on cross-functional teams and providing strategic leadership for Penumbra-sponsored clinical studies.
Recruit, hire, and directly supervise team members, allocating resources and managing project timelines to meet departmental goals.
Penumbra is a global healthcare company focused on innovative therapies. It designs, develops, and markets novel products and fosters a collaborative teamwork environment.
Lead or contribute to the design and execution of rigorous research and evaluation projects, applying qualitative or quantitative methods to collect, manage, analyze, and interpret data.
Translate complex findings into actionable insights for client reports, technical memos, and presentations, and support proposal development by writing technical sections and developing budgets.
Manage small to mid-sized tasks, mentor junior staff, and engage with stakeholders through meetings and briefings to foster a collaborative work environment.
American Institutes for Research (AIR) is a nonpartisan, not-for-profit organization that conducts behavioral and social science research and delivers technical assistance to address pressing challenges. Founded in 1946 and headquartered in Arlington, Virginia, AIR focuses on generating evidence and applying data-driven solutions to expand opportunities and improve lives.
Oversee contract development and manufacturing organizations for drug substance process chemistry activities, focusing on late-stage and validation.
Author and manage RFP documents, support regulatory submissions, and provide technical expertise for manufacturing scale-up and troubleshooting.
Interface proactively with CMC team members and communicate process chemistry strategies effectively across departments.
BridgeBio pioneers a 'moneyball for biotech' approach, pooling projects and early-stage research from academia to reduce risk and develop life-changing medicines for rare diseases. The company fosters a culture of curiosity and experimentation, empowering teams to push boundaries and achieve the impossible.
Plan and execute development experiments for Freenome's multiomics cancer screening tests.
Partner cross-functionally with computational, development, regulatory, and quality teams to develop a regulated strategy toward FDA approval.
Use quantitative skills to develop computational methods and interpret complex experimental results to optimize and validate innovative technology.
Freenome is a biotechnology company developing early, noninvasive blood-based tests for cancer detection. The company emphasizes a highly collaborative, cross-functional environment and values diversity.
Oversee evidence-generation strategy and manage research studies for the da Vinci Cardiac Surgery Program.
Collaborate with stakeholders to identify evidence gaps, align priorities, and develop evidence-generation plans.
Manage CROs, research partners, and publications while ensuring regulatory compliance and audit readiness.
Intuitive is a global leader in robotic-assisted surgery and minimally invasive care, with technologies like the da Vinci system transforming care for millions worldwide. We are a team of engineers, clinicians, and innovators united to make surgery smarter, safer, and more human.
Monitor and own study progress at sites, ensuring compliance with protocol, SOPs, ICH-GCP, and regulations.
Coordinate setup: investigators, regulatory submissions, pre-study and initiation visits.
Identify risks, propose mitigations, and become a protocol expert with a lower protocol load.
Precision for Medicine is a clinical research organization that combines novel clinical trial designs, advanced biomarker and data analytics, and specialized expertise in rare diseases and oncology. It is a smaller CRO with high CRA retention, a supportive culture, and a focus on giving employees influence and impact.
Lead data management activities from study start-up to database lock, ensuring quality and timelines.
Act as subject matter expert for DM in sponsor meetings and implement process improvements.
Mentor and train junior DM staff while managing project documentation, data validation, and system setup.
Fortrea is a global contract research organization providing clinical development and biometrics services to pharmaceutical and biotechnology companies. With a focus on teamwork and excellence, they foster a family-like culture where employees collaborate to advance life-saving therapies.
Contribute to the technical approach for evaluating AI agent performance across the genetic medicines pipeline, including gene therapy, gene editing, and RNA therapeutics.
Design realistic program case studies spanning target validation, drug design, screening, chemistry optimization, and IND-enabling studies.
Review and stress-test AI agent outputs for scientific soundness, calibrating confidence on preclinical data with incomplete or conflicting signals.
Latch builds rigorous scientific benchmarks for AI agents across biology, working with frontier labs and pharma to measure whether agents can handle real biological workflows. The culture emphasizes radical transparency, high agency, and using AI tools with original expert judgment.